<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font25 { font-size : 25; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">migraine </span>
   <span class="font25">aura </span>
   <span class="font16">patients </span>
   <span class="font14">attacks </span>
   <span class="font14">headache </span>
   <span class="font13">treatment </span>
   <span class="font13">study </span>
   <span class="font12">aura, </span>
   <span class="font12">aura. </span>
   <span class="font12">Migraine </span>
   <span class="font12">acute </span>
   <span class="font12">studies </span>
   <span class="font11">Cephalalgia </span>
   <span class="font11">associated </span>
   <span class="font11">{border-style </span>
   <span class="font11">./j.-...x </span>
   <span class="font11">CSD </span>
   <span class="font11">international </span>
   <span class="font11">Headache </span>
   <span class="font11">Neurol </span>
   <span class="font11">px;} </span>
   <span class="font11">symptoms </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">clinical </span>
   <span class="font11">reported </span>
   <span class="font11">risk </span>
   <span class="font11">pain </span>
   <span class="font11">depression </span>
   <span class="font11">effect </span>
   <span class="font11">placebo </span>
   <span class="font11">efficacy </span>
   <span class="font11">reduction </span>
   <span class="font11">spreading </span>
   <span class="font11">systematic </span>
   <span class="font11">based </span>
   <span class="font11">cortical </span>
   <span class="font11">difference </span>
   <span class="font11">sumatriptan </span>
   <span class="font11">trial </span>
   <span class="font11">aura: </span>
   <span class="font11">compared </span>
   <span class="font11">migraine: </span>
   <span class="font11">review </span>
   <span class="font11">significant </span>
   <span class="font10">Neurology </span>
   <span class="font10">brain </span>
   <span class="font10">different </span>
   <span class="font10">foramen </span>
   <span class="font10">magnetic </span>
   <span class="font10">number </span>
   <span class="font10">randomized, </span>
   <span class="font10">trials </span>
   <span class="font10">visual </span>
   <span class="font10">= ) </span>
   <span class="font10">Society </span>
   <span class="font10">double-blind, </span>
   <span class="font10">frequency </span>
   <span class="font10">increased </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">preventive </span>
   <span class="font10">prophylaxis </span>
   <span class="font10">therapeutic </span>
   <span class="font10">vs. </span>
   <span class="font10">./s--- </span>
   <span class="font10">Sumatriptan </span>
   <span class="font10">aspirin </span>
   <span class="font10">attack </span>
   <span class="font10">changes </span>
   <span class="font10">open-label </span>
   <span class="font10">patients, </span>
   <span class="font10">px; </span>
   <span class="font10">randomized </span>
   <span class="font10">reduced </span>
   <span class="font10">therapy </span>
   <span class="font10">topiramate </span>
   <span class="font10">{font-family </span>
   <span class="font10">NNT </span>
   <span class="font10">Neurological </span>
   <span class="font10">cause </span>
   <span class="font10">controlled </span>
   <span class="font10">differences </span>
   <span class="font10">duration </span>
   <span class="font10">font-size </span>
   <span class="font10">group </span>
   <span class="font10">headache, </span>
   <span class="font10">important </span>
   <span class="font10">ischemic </span>
   <span class="font10">magnesium </span>
   <span class="font10">placebo-controlled </span>
   <span class="font10">response </span>
   <span class="font10">stroke </span>
   <span class="font10">treatments </span>
   <span class="font10">Charles </span>
   <span class="font10">Clinical </span>
   <span class="font10">Derry </span>
   <span class="font10">Italian </span>
   <span class="font10">Lancet </span>
   <span class="font10">Olesen </span>
   <span class="font10">data </span>
   <span class="font10">did </span>
   <span class="font10">double; </span>
   <span class="font10">drugs </span>
   <span class="font10">glutamate </span>
   <span class="font10">mechanisms </span>
   <span class="font10">occur </span>
   <span class="font10">ovale </span>
   <span class="font10">patent </span>
   <span class="font10">prophylactic </span>
   <span class="font10">role </span>
   <span class="font10">sTMS </span>
   <span class="font10">stroke, </span>
   <span class="font10">suggesting </span>
   <span class="font10">symptom </span>
   <span class="font10">tested </span>
   <span class="font10">used </span>
   <span class="font10">./S-()- </span>
   <span class="font10">./ana. </span>
   <span class="font10">Ann </span>
   <span class="font10">Eur </span>
   <span class="font10">Hansen </span>
   <span class="font10">International </span>
   <span class="font10">Memantine </span>
   <span class="font10">NMDA </span>
   <span class="font10">Topiramate </span>
   <span class="font10">Transcranial </span>
   <span class="font10">analysis </span>
   <span class="font10">auras </span>
   <span class="font10">available </span>
   <span class="font10">barrier </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cerebral </span>
   <span class="font10">drug </span>
   <span class="font10">effective </span>
   <span class="font10">examined </span>
   <span class="font10">general </span>
   <span class="font10">higher </span>
   <span class="font10">however, </span>
   <span class="font10">including </span>
   <span class="font10">individual </span>
   <span class="font10">intensity </span>
   <span class="font10">ketamine </span>
   <span class="font10">lamotrigine </span>
   <span class="font10">link </span>
   <span class="font10">phase </span>
   <span class="font10">population </span>
   <span class="font10">provide </span>
   <span class="font10">receptor </span>
   <span class="font10">relief </span>
   <span class="font10">results </span>
   <span class="font10">retrospective </span>
   <span class="font10">solid; </span>
   <span class="font10">statistically </span>
   <span class="font10">stimulation </span>
   <span class="font10">study, </span>
   <span class="font10">suggest </span>
   <span class="font10">triptans </span>
   <span class="font10">versus </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10"> mg </span>
   <span class="font10">(): </span>
   <span class="font10">(.%) </span>
   <span class="font10">American </span>
   <span class="font10">Aura </span>
   <span class="font10">Based </span>
   <span class="font10">Brain </span>
   <span class="font10">Clin </span>
   <span class="font10">Med </span>
   <span class="font10">Neurology, </span>
   <span class="font10">PFO </span>
   <span class="font10">Pain </span>
   <span class="font10">Suppl </span>
   <span class="font10">activation </span>
   <span class="font10">adults </span>
   <span class="font10">animal </span>
   <span class="font10">association </span>
   <span class="font10">blood-brain </span>
   <span class="font10">bold </span>
   <span class="font10">chronic </span>
   <span class="font10">closure </span>
   <span class="font10">cognitive </span>
   <span class="font10">cortex </span>
   <span class="font10">courier; </span>
   <span class="font10">disability </span>
   <span class="font10">disease </span>
   <span class="font10">dysfunction </span>
   <span class="font10">eletriptan </span>
   <span class="font10">em; </span>
   <span class="font10">especially </span>
   <span class="font10">gain </span>
   <span class="font10">given </span>
   <span class="font10">high </span>
   <span class="font10">imaging </span>
   <span class="font10">intranasal </span>
   <span class="font10">likely </span>
   <span class="font10">migraine, </span>
   <span class="font10">neurological </span>
   <span class="font10">observational </span>
   <span class="font10">official </span>
   <span class="font10">placebo-controlled, </span>
   <span class="font10">population-based </span>
   <span class="font10">potential </span>
   <span class="font10">prevention </span>
   <span class="font10">prolonged </span>
   <span class="font10">pt;} </span>
   <span class="font10">remains </span>
   <span class="font10">represents </span>
   <span class="font10">sham </span>
   <span class="font10">similar </span>
   <span class="font10">simulation </span>
   <span class="font10">studies. </span>
   <span class="font10">study. </span>
   <span class="font10">taken </span>
   <span class="font10">therapies </span>
   <span class="font10">transcranial </span>
   <span class="font10">use </span>
   <span class="font10">vascular </span>
   <span class="font10">women </span>
  </p>
 </body>
</html>
